TrialNCT07632898Phase 3Not yet recruiting
Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH)
Study sponsor: Inhibikase Therapeutics
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2030-06-30Estimated
Enrollment · participants484Estimated
Source updated2026-06-08Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.